Company: PED
Filing Date: 2025-10-29
Form Type: 10-K/A
Source: 0001654954-25-012328
Chunk: 160

Company: PEDEVCO CORP
Filing Date: 2025-10-29
Form: 10-K/A
Chunk 160
---
 2024, restricted stock awards were granted to officers and employees of the Company for an aggregate of shares of the Company’s restricted common stock, under the Company’s 2021 Plan. each subsequent year from the date of grant contingent upon the recipient’s continued service with the Company. These shares have a total fair value of $ based on the market price on the grant date.

On August 29, 2024, an aggregate of restricted stock awards were granted to two board members under the Company’s 2021 Plan. , contingent upon each recipient’s continued service with the Company. These shares have a total fair value of $, based on the market price on the grant date.

On May 24, 2024, 70,000 shares of restricted common stock were forfeited due to an employee termination. As a result, these shares were canceled, and the shares once again became eligible for future awards under the Company’s 2021 Plan.

On January 23, 2023, an aggregate of shares of restricted common stock were granted to officers of the Company under the Company’s 2021 Plan. each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company. These shares had a total fair value of $ based on the market price on the issuance date.

On August 31, 2023, an aggregate of restricted stock awards were granted to two board members under the Company’s 2021 Plan. , contingent upon each recipient’s continued service with the Company. These shares have a total fair value of $ based on the market price on the grant date.

The awarded shares above are subject to trading restrictions, and forfeiture, subject to the vesting terms described above. When such securities are vested in accordance with their terms, the trading restrictions are lifted.

Stock-based compensation expense recorded related to restricted stock during the years ended December 31, 2024 and 2023 was $ and $, respectively. The remaining amount of unamortized stock-based compensation expense related to restricted stock at December 31, 2024 and 2023 was $ and $, respectively.

| 111 |

Options

On January 26, 2024, the Company granted options to purchase an aggregate of shares of common stock to various Company employees at an exercise price of $ per share under the Company’s 2021 Plan. . The aggregate fair value of the options on the date of grant, using the Black-Scholes model, was $. Variables used in the Black-Scholes